Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
ACS Infect Dis ; 10(5): 1644-1653, 2024 05 10.
Article in English | MEDLINE | ID: mdl-38602317

ABSTRACT

This study describes the synthesis of amino-functionalized carbon nanoparticles derived from biopolymer chitosan using green synthesis and its application toward ultrasensitive electrochemical immunosensor of highly virulent Escherichia coli O157:H7 (E. coli O157:H7). The inherent advantage of high surface-to-volume ratio and enhanced rate transfer kinetics of nanoparticles is leveraged to push the limit of detection (LOD), without compromising on the selectivity. The prepared carbon nanoparticles were systematically characterized by employing CO2-thermal programmed desorption (CO2-TPD), Fourier transform infrared (FTIR) spectroscopy, X-ray photoelectron spectroscopy (XPS), ultraviolet-visible (UV-visible), and transmission electron microscopy (TEM). The estimated limit of detection of 0.74 CFU/mL and a sensitivity of 5.7 ((ΔRct/Rct)/(CFU/mL))/cm2 in the electrochemical impedance spectroscopy (EIS) affirm the utility of the sensor. The proposed biosensor displayed remarkable selectivity against interfering species, making it well suited for real-time applications. Moreover, the chitosan-derived semiconducting amino-functionalized carbon shows excellent sensitivity in a comparative analysis compared to highly conducting amine-functionalized carbon synthesized via chemical modification, demonstrating its vast potential as an E. coli sensor.


Subject(s)
Biosensing Techniques , Carbon , Chitosan , Dielectric Spectroscopy , Escherichia coli O157 , Escherichia coli O157/isolation & purification , Biosensing Techniques/methods , Carbon/chemistry , Chitosan/chemistry , Nanoparticles/chemistry , Limit of Detection , Green Chemistry Technology
2.
Biosens Bioelectron ; 241: 115674, 2023 Dec 01.
Article in English | MEDLINE | ID: mdl-37717423

ABSTRACT

Chronic wounds caused due to bacterial biofilms are detrimental to a patient, and an immediate diagnosis of these bacteria can aid in an effective treatment, which is still an unmet clinical need. An instant and accurate identification of bacterial type could be made by utilizing the Toll-Like Receptors (TLRs) combined with Myeloid Differentiation factor 2 (MD-2). Given this, we have developed an electrochemical sensing platform to identify the gram-negative (gram-ve) bacteria using TLR4/MD-2 complex. The nonthermal plasma (NTP) technique was utilized to functionalize amine groups onto the carbon surface to fabricate cost-effective carbon paste working electrodes (CPEs). The proposed electrochemical sensor platform with a specially engineered electrochemical cell (E-Cell) identified the Escherichia coli (E. coli) in a wide linear range of 1.5×10° - 1.5×106 C.F.U./mL, accounting for a very low detection limit of 0.087 C.F.U./mL. The novel and cost-effective sensor platform identified gram-ve bacteria predominantly in a mixture of gram positive (gram+ve) bacteria and fungi. Further, towards real-time detection of bacteria and point-of-care (PoC) applications, the effect of the pond water matrix was studied, which was minimal, and the sensor could identify E. coli concentrations selectively, showing the potential application of the proposed platform towards real-time bacterial detection.

3.
Anal Chim Acta ; 1233: 340482, 2022 Nov 15.
Article in English | MEDLINE | ID: mdl-36283776

ABSTRACT

In chronic wounds, rapid identification of the bacterial type is critical for immediate clinical assessment. A novel, cost-effective, and label-free electrochemical nanobiosensor was developed with the help of an indigenously fabricated carbon paste working electrode to rapidly identify the bacterial type. The proposed platform made use of gold nanoparticles (AuNPs) to boost electrochemical activity, and the strong affinity of boronic acid moieties for diols allowed for detection and differentiation of gram + ve and gram -ve bacteria on the same platform. A scalable and robust miniaturized Electrochemical Cell (E-Cell) designed for the developed electrodes assisted in reducing sample waste, detection time, and Limit of Detection (LOD). Within 15 min, the proposed nano biosensing platform identified Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) bacteria with an excellent recovery rate for the blind samples. Because of its size and the extra lipopolysaccharides (LPS) layer containing diols, the bioelectrode demonstrated a superior response to E. coli, effectively distinguishing it from S. aureus. Furthermore, the proposed biosensing platform demonstrated an excellent shelf-life and reproducibility with acceptable selectivity and exhibited an excellent specificity towards bacteria, making it an ideal candidate for rapid identification of the bacterial type.


Subject(s)
Biosensing Techniques , Metal Nanoparticles , Gold/chemistry , Electrochemical Techniques , Metal Nanoparticles/chemistry , Staphylococcus aureus , Escherichia coli/chemistry , Lipopolysaccharides , Reproducibility of Results , Limit of Detection , Electrodes , Carbon/chemistry , Boronic Acids
4.
ACS Omega ; 7(24): 21025-21034, 2022 Jun 21.
Article in English | MEDLINE | ID: mdl-35755381

ABSTRACT

Nonthermal plasma, a nondestructive, fast, and highly reproducible surface functionalization technique, was used to introduce desired functional groups onto the surface of carbon powder. The primary benefit is that it is highly scalable, with a high throughput, making it easily adaptable to bulk production. The plasma functionalized carbon powder was later used to create highly specific and low-cost electrochemical biosensors. The functional groups on the carbon surface were confirmed using NH3-temperature-programmed desorption (TPD) and X-ray photoelectron spectroscopy (XPS) analysis. In addition, for biosensing applications, a novel, cost-effective, robust, and scalable electrochemical sensor platform comprising in-house-fabricated carbon paste electrodes and a miniaturized E-cell was developed. Biotin-Streptavidin was chosen as a model ligand-analyte combination to demonstrate its applicability toward biosensor application, and then, the specific identification of the target Escherchia coli O157:H7 was accomplished using an anti-E. coli O157:H7 antibody-modified electrode. The proposed biosensing platform detected E. coli O157:H7 in a broad linear range of (1 × 10-1-1 × 106) CFU/mL, with a limit of detection (LOD) of 0.1 CFU/mL. In addition, the developed plasma functionalized carbon paste electrodes demonstrated high specificity for the target E. coli O157:H7 spiked in pond water, making them ideal for real-time bacterial detection.

SELECTION OF CITATIONS
SEARCH DETAIL